Market revenue in 2023 | USD 48.5 million |
Market revenue in 2030 | USD 79.4 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 46.39% in 2023. Horizon Databook has segmented the Europe cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
The European healthcare system is witnessing a shift from inpatient to outpatient care, which is driven by availability of advanced medical equipment, treatment methods, and protocols. The number of people above the age of 65 is growing rapidly in Europe, thus increasing the demand for better healthcare facilities.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account